OpenAI says it has removed the “warning” messages in its AI-powered chatbot platform, ChatGPT, that indicated when content might violate its terms of service. Laurentia Romaniuk, a member of OpenAI’s AI model behavior team, said in a post on X that the change was intended to cut down on “gratuitous/unexplainable denials.” Nick Turley, head of […] © 2024 TechCrunch. All rights reserved. For personal use only.
Wanda Maximoff, the Scarlet Witch, is one of the most powerful beings in the Marvel Universe, and she can wreak havoc on your enemies in Rivals once you have mastered her arcane skill set.Read more...
Druckerhersteller empfehlen, das Papier vor dem Einlegen in den Drucker aufzufächern. Wir zeigen euch, wie das schnell und einfach geht.
AVGR has been behaving with a lot of volatility, but something is happening behind the scenes.
The triple bottom chart pattern usually emerges after an extended downtrend with bears dominating the market. While the first bottom might reflect regular price fluctuations, the second bottom signals that the bulls are gathering strength and gearing up for a potential reversal. The third bottom demonstrates robust support, suggesting that bears may surrender when the price surpasses resistance levels. ALSO: Investing in Recursion Pharmaceuticals (RXRX) offers intriguing possibilities for several reasons: Innovative Technology: NASDAQ:RXRX utilizes artificial intelligence (AI) and machine learning to expedite drug discovery. Their BioHive-2 supercomputer, powered by Nvidia AI chips, is among the most powerful accelerated computing systems globally. Partnerships: NASDAQ:RXRX has formed alliances with major tech and healthcare leaders, including Nvidia ( NASDAQ:NVDA ), which invested $50 million into its operations. These collaborations aim to streamline drug discovery, making it faster and more cost-effective. Promising Pipeline: NASDAQ:RXRX boasts a strong lineup of drug candidates, and their technology has already shown promising results. Their merger with Exscientia, another biotech company focused on AI-driven drug discovery, has created a more robust, vertically integrated platform. Potential for High Returns: While investing in NASDAQ:RXRX involves risks, it also holds the potential for significant returns. The company's innovative approach could transform the healthcare industry, making it a potential "10-bagger" (a stock that increases tenfold in value). Long-term Vision: RXRX seeks to shorten the drug discovery process from years to months and significantly reduce costs. This long-term vision could lead to substantial growth if successful.
Market is approaching a strong level of support(prev resistance) - Break and retest Theory Trend is bullish therefore expecting an impulsive move to break prev structure. Currently waiting for bullish momentum and break of a prev candle to enter the trade!
Can you see here devergens? This is a test idea Can you see here devergens? This is a test idea Can you see here devergens? This is a test idea Can you see here devergens? This is a test idea Can you see here devergens? This is a test idea Can you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test ideaCan you see here devergens? This is a test idea
AUCTIONUSDT(AUCTION) Daily timeframe range. PA trying to recover to midrange here. its possible if we can get a valid close above 12.54. volume is decent here a little more would help to clear out the resistance. recent support at 8.29.
Looks like a very long time of stagnation is ahead. Let’s be patient and wait for a miracle ?
Even though this may be an extremely unpopular opinion on this topic, realizing this simple truth may be what makes or breaks a profitable trader. The truth is this... Drawing lines on a chart does not predict any price movement, and there are more factors in play than simply price action It doesn't matter what the gurus on the internet say about some "secret strategy" or a "secret indicator", anyone with common sense should automatically ignore content like that. Firms like NYSE:JPM , NYSE:GS , NYSE:MS , etc. , spend billions upon billions of dollars just to figure out how to trade the market with efficiency, but some random 19 year old on the internet figured out how to beat these mega-firms with a free indicator. Yeah right. However, I'm not saying that technical analysis doesn't work or that it shouldn't be used; I'm simply saying to reconsider your strategy and use common sense before donating your money to Wall Street banks. Below is an example of technical analysis working perfectly on NYSE:UNH for the 1D timeframe looking back into April of last year. https://www.tradingview.com/x/t3zjPIp0/ This would have been a textbook channel breakout trade, in which the trader takes a short when the bottom trendline is broken (or the candle closes below the trendline). It would have resulted in a maximum of 17% gain on naked short shares if the bottom penny is the exit price (which is virtually impossible). So there you have it... technical analysis works perfectly and I have proven myself wrong.... right? No. . Now let me show you what really happened. Here is the same exact chart, but this time with a piece of key information shown. https://www.tradingview.com/x/CbH0LY5G/ As it turns out, there was nothing technical in play at all in this price action, but rather a "fundamental" or a "tangible" aspect was the price driver. An example like this should also show you that not providing sufficient information and taking charts out of context can be done by literally anyone. If you think you can predict the future with some geometric shapes, bars, and non financial, fundamental, or tangible analysis, better than the top Wall Street firms, I say good luck to you. WITH THAT BEING SAID, this does not mean that trendlines, price areas, value gaps, and other technical indicators are completely invalid, but it does mean that there is more to the story than what is on the chart. Always review news, sentiment, financials, analyst ratings, and other key oscillators to gauge every trade. Disclaimer: The indicators used on the chart are only for illustrative purposes of a cluttered chart. I am neither saying that they are accurate nor inaccurate.